A pilot study of vidofludimus calcium for treatment of primary sclerosing cholangitis

A pilot study of vidofludimus calcium for treatment of primary sclerosing cholangitis

Abstract The purpose of this pilot study was to explore the efficacy, safety, and tolerability of vidofludimus calcium (VC) in the treatment of primary sclerosing cholangitis (PSC). This was a single‐arm open‐label pilot study with a cohort of 18 patients with PSC. Study patients received VC for a p...

Full description

Bibliographic Details
Main Authors: Elizabeth J. Carey, John Eaton, Mitchell Clayton, Andrea Gossard, Sara Iqbal, Hamid Ullah, Nan Zhang, Richard Butterfield, Keith D. Lindor
Format: Article
Language:English
Published: Wolters Kluwer Health/LWW 2022-07-01
Series:Hepatology Communications
Online Access:https://doi.org/10.1002/hep4.1926

Internet

https://doi.org/10.1002/hep4.1926

Similar Items